The three main subsets identified in the cluster analysis showed no significant differences with regard to age, cause of AML (de novo versus secondary), morphological signs of differentiation (FAB classification), expression of the CD34 stem cell marker, karyotype, FLT3-ITD, or NPM1 mutations (data not shown). The gene discussed is CD34; the disease is acute myeloid leukemia.